Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Código QR

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Michael A Via1, Himani Chandra2, Takako Araki1, Matthew V Potenza3, Maria Skamagas41Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY, USA; 2Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, Jam...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Via MA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Bromocriptine Dopamine Agonists Diabetes Glycemic Control Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/cb1201f357514f8c890611a7afef052d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Michael A Via, et al.
Publicado: (2010)

The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
por: Yunzhi Zou, et al.
Publicado: (2021)

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
por: Fasil A, et al.
Publicado: (2018)

Poor Glycemic Control and Its Contributing Factors Among Type 2 Diabetes Patients at Adama Hospital Medical College in East Ethiopia
por: Yosef T, et al.
Publicado: (2021)

Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study
por: YimamAhmed M, et al.
Publicado: (2020)

The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas
por: Shuman Wang, et al.
Publicado: (2021)

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
por: Alzaheb RA, et al.
Publicado: (2018)

Cardiovascular Risk Prediction, Glycemic Control, and Determinants in Diabetic and Hypertensive Patients in Massawa Hospital, Eritrea: Cross-Sectional Study on 600 Subjects
por: Tesfai B, et al.
Publicado: (2021)

Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study
por: Ahmadieh H, et al.
Publicado: (2018)

Racial Variation in the Relationship of Glycemic Control with Fracture Risk in Elderly Patients with Diabetes
por: Figaro MK, et al.
Publicado: (2020)

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
por: Lee J, et al.
Publicado: (2019)

Level of Adherence to the Dietary Recommendation and Glycemic Control Among Patients with Type 2 Diabetes Mellitus in Eastern Ethiopia: A Cross-Sectional Study
por: Mohammed AS, et al.
Publicado: (2020)

Relationship Between Long-Term Objectively Measured Physical Activity and Glycemic Control in Type 2 Diabetes Mellitus Patients: A Prospective Cohort Study
por: Masuda H, et al.
Publicado: (2021)

Impact of food pattern on glycemic control among type 2 diabetic patients: a cross-sectional study in the United Arab Emirates
por: Sadiya A, et al.
Publicado: (2019)

Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in China
por: Liu G, et al.
Publicado: (2020)

Optimizing glycemic control in type 2 diabetic patients through the use of a low-carbohydrate, high-fat, ketogenic diet: a review of two patients in primary care
por: Rallis S
Publicado: (2019)

Poor Glycemic Control and the Contributing Factors Among Type 2 Diabetes Mellitus Patients Attending Outpatient Diabetes Clinic at Mbarara Regional Referral Hospital, Uganda
por: Patrick NB, et al.
Publicado: (2021)

Physical Exercise is Associated with Glycemic Control among Women with Gestational Diabetes Mellitus: Findings from a Prospective Cohort in Shanghai, China
por: Wang R, et al.
Publicado: (2021)

A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
por: A Ahmadi Ahangar, et al.
Publicado: (2002)

Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control
por: Lam PY, et al.
Publicado: (2021)

A Review of Research Progress on Glycemic Variability and Gestational Diabetes
por: Yu W, et al.
Publicado: (2020)

Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus
por: Bukhsh A, et al.
Publicado: (2019)

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
por: Ahmadieh H, et al.
Publicado: (2017)

The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
por: Zare Javid A, et al.
Publicado: (2020)

Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming  Co-Epidemics
por: Melaku T, et al.
Publicado: (2020)

Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
por: Wake AD
Publicado: (2020)

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
por: Mohammed Fouad Shalaby, MD, et al.
Publicado: (2021)

Resistant Starch Consumption Effects on Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes: A Randomized Crossover Study
por: Yolanda Arias-Córdova, et al.
Publicado: (2021)

Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial
por: Karamzad N, et al.
Publicado: (2020)

Estimating the Risk of Insulin Requirement in Women Complicated by Gestational Diabetes Mellitus: A Clinical Nomogram
por: Du R, et al.
Publicado: (2021)

Self-Monitoring of Blood Glucose and Hypoglycemia Association During Fasting in Ramadan Among Patients with Diabetes
por: Mansouri D, et al.
Publicado: (2020)

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes
por: Takahara M, et al.
Publicado: (2020)

Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options
por: Du YF, et al.
Publicado: (2014)

The Effect of Physical Activity on Glycemic Variability in Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Xingyun Zhu, et al.
Publicado: (2021)

Dopamine, a co-regulatory component, bridges the central nervous system and the immune system
por: Mingan Li, et al.
Publicado: (2022)

Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients
por: Derosa G, et al.
Publicado: (2019)

Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Chen HJ, et al.
Publicado: (2021)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
por: Gebrie D, et al.
Publicado: (2021)

FACTORS ASSOCIATED WITH POOR GLYCEMIC CONTROL AMONG TYPE 2 DIABETES MELLITUS IN INDONESIA
por: Rian Adi Pamungkas, et al.
Publicado: (2017)

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
por: Qiao Q, et al.
Publicado: (2016)